Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortBlood thinner with its own antidote.Twice-daily blood thinner without routine monitoring.
Body systemBlood & ClottingBlood & Clotting
Drug classDirect oral anticoagulantsDirect oral anticoagulants
SupplyPrescription onlyPrescription only
Main usesStroke prevention in atrial fibrillation, DVT and pulmonary embolism, Clot prevention after joint replacementStroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolism, Clot prevention after hip or knee replacement
How it worksBlocks thrombin, the final enzyme that forms a clot.Blocks one key clotting protein directly.
Starts working—3–4 hours
Half-life12–17 hoursAbout 12 hours
Typical adult dose150 mg twice a day (110 mg twice a day over 80 or with bleeding risk).AF: 5 mg twice a day (2.5 mg if two of: age ≥80, weight ≤60 kg, poor kidney function). Clot treatment: 10 mg twice a day for 7 days, then 5 mg twice a day.
FormsCapsule, Oral pelletsTablet
Common side effectsIndigestion, Stomach pain, BruisingBruising, Nosebleeds, Heavy periods
Serious side effectsMajor bleeding, Gut bleedingMajor bleeding, Bleeding in the brain (less than with warfarin)
Don't take if—Active major bleeding; Severe liver disease with clotting abnormalities; Mechanical heart valve; Taking strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir) without review
Alcohol—Best to limit. Alcohol raises bleeding risk.
PregnancyUsually avoidedNot used in pregnancy.Usually avoidedNot used in pregnancy; low-molecular-weight heparin is preferred.
Breastfeeding—Usually avoidedAvoid.
In use since20082012
Brand namesUnited States: PradaxaUnited Kingdom: PradaxaIndia: Pradaxa, DabigatUnited States: EliquisUnited Kingdom: EliquisIndia: Eliquis, Apigat
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeB01AE07B01AF02

Taken together

  • MajorDabigatran + Apixaban: Double anticoagulation — serious bleeding risk

    Two blood thinners together greatly increase the risk of major bleeding.

Open in the interaction checker